Placental transfer of Δ9-tetrahydrocannabinol (THC) during pregnancy has the potential to interfere with endogenous cannabinoid (CB) regulation of fetal nervous system development in utero. Here we examined the effect of maternal CB intake on mouse hippocampal interneurons largely focusing on cholecystokinin-expressing interneurons (CCK-INTs), a prominent CB subtype-1 receptor (CB1R) expressing neuronal population throughout development. Maternal treatment with THC or the synthetic CB1R agonist WIN55,212-2 (WIN) produced a significant loss of CCK-INTs in the offspring. Further, residual CCK-INTs in animals prenatally treated with WIN displayed decreased dendritic complexity. Consistent with these anatomical deficits, pups born to CB-treated dams exhibited compromised CCK-INT-mediated feedforward and feedback inhibition. Moreover, pups exposed to WIN in utero lacked constitutive CB1R-mediated suppression of inhibition from residual CCK-INTs and displayed altered social behavior. Our findings add to a growing list of potential cell/circuit underpinnings that may underlie cognitive impairments in offspring of mothers that abuse marijuana during pregnancy.
INTRODUCTION
Marijuana is one of the most widely abused illicit drugs among pregnant women, 1 and the ever-increasing social and legal acceptance of recreational cannabis use is likely to escalate consumption within this cohort. As Δ9-tetrahydrocannabinol (THC), the major psychoactive ingredient in marijuana, efficiently undergoes cross-placental transfer, maternal cannabis use has the potential to interfere with ongoing fetal development in utero. 2 Given the rise in THC content of recreationally available cannabis strains and the increasing prevalence of potent cannabis-based waxes/oils, even moderate consumption during pregnancy may be sufficient to disrupt embryonic development. 3, 4 Although regulatory obstacles have limited research on prenatal cannabis exposure, a handful of studies in both human subjects and animal models have established that prenatal and perinatal cannabis exposure promotes various cognitive, behavioral and neuropsychiatric defects, indicating that embryonic nervous system patterning is particularly susceptible to maternal cannabis abuse. [5] [6] [7] [8] [9] However, the cellular and molecular mechanisms underlying prenatal THC-induced changes in neuronal circuitry remain poorly understood.
In the brain, THC acts at the cannabinoid (CB) family of receptors, where it can disrupt cellular communication mediated by the endogenous CBs 2-arachidonyl glycerol or anandamide. 10 During nervous system development, endocannabinoid (eCB) signaling, primarily through CB subtype-1 receptors (CB1Rs), has been implicated in neuronal proliferation, migration, morphogenesis and synaptogenesis. [11] [12] [13] In particular, a number of studies have implicated CB1R signaling as critical for proper axon pathfinding and connectivity of developing neocortical glutamatergic long-range projection neurons. [13] [14] [15] [16] [17] [18] During embryonic development, CB1Rs are also strongly expressed by caudal ganglionic eminence (CGE)-derived GABAergic interneurons (INTs) and, in the mature brain, hippocampal cholecystokinin-expressing INTs (CCK-INTs) are the dominant CB1R-expressing neuronal population. 11, 12, [19] [20] [21] [22] The long tangential migration necessary for CGE-derived INTs to reach the hippocampus combined with the known influence of eCB signaling on CCK-INT growth cone dynamics, migration and morphogenesis suggests that these cells may be particularly vulnerable to maternal CB intake. 11, 12, 22 Thus, we examined how chronic prenatal exposure to exogenous CBs influences postnatal CCK-INT patterning and function using combined immunohistochemistry, electrophysiology and behavioral analyses.
We found that prenatal exposure to exogenous CBs significantly reduces the density of CCK-INTs and similarly reduces the density of CCK axon terminals in CA1 stratum pyramidal. These anatomical deficits translate to a reduction in CCK-INT-mediated spontaneous synaptic inhibition and CCK-INT-mediated feedforward and feedback inhibition in the CA1 microcircuit. Further, we demonstrate a loss of constitutive CB1R activity in residual CCK-INTs and concomitant deficits in social interactions of mice following prenatal exogenous CB treatment. These findings add to a growing list of cellular and network deficits that may underlie neurobehavioral deficits observed in individuals exposed to exogenous CBs in utero following maternal cannabis use.
MATERIALS AND METHODS Animals
All experiments were conducted in accordance with animal protocols approved by NIH. All experiments were performed on 5HT3AR-GFP or Nkx2.1-cre:RCE-GFP reporter lines as indicated. Timed pregnancy was performed by breeding male transgenics with either wild-type C57/BL6 or transgenic females. The date of plug was noted as embryonic day 0.5 (E0.5). Pregnant females were then given daily intraperitoneal injections with THC (5 mg kg − 1 , suspended in 5% ethanol+5% corn oil in saline) or WIN55,212-2 (WIN; 0.75 mg kg − 1 , suspended in 0.3% Tween 80 in saline) from E10.5-E18. 5 . Experiments were then performed on the offspring age p14-p45 as indicated. Exogenous CB (THC or WIN)-treated females were always run in parallel with a corresponding vehicle (VH)treated mouse so that each THC or WIN litter could be assayed in parallel with an appropriate VH control litter. Females used for injection were only used once, to minimize potential for cross-generational effects of CB administration.
Immunohistochemistry
For immunohistochemical analyses, mice were perfused transcardially using 4% paraformaldehyde/1 × phosphate-buffered saline (PBS) solution. Brains were removed and postfixed overnight at 4°C followed by cryoprotection using 25% sucrose/1 × PBS solution. Horizontal sections (50 μm) were cut on a freezing microtome and washed in 1 × PBS. For parvalbumin (PV), somatostatin (SOM), calretinin, vasoactive intestinal peptide, CB1R and embryonic green fluorescent protein (GFP) labeling, brain slices were permeabilized and blocked in 1 × PBS+1% bovine serum albumin+10% normal goat serum+0.5% Triton X-100 (Carrier PB) at room temperature for 2 h, followed by incubation in primary antibodies diluted with 1 × PBS+1% bovine serum albumin+1% normal goat serum + 0.1% Triton X-100 (Carrier Solution: mouse anti-PV (Sigma, St Louis, MO, USA, P3088), 1:3000; rabbit anti-SOM (DAKO, Carpinteria, CA, USA A0566), 1:1000; rabbit anti-calretinin (Millipore/Chemicon, Billerica, MA, USA, AB5054), 1:1000; guinea pig anti vasoactive intestinal peptide (Penisula Laboratories, San Carlos, CA, USA, T-5030), 1:1000; rabbit anti-CB1R (Cayman, Ann Arbor, MI, USA, 10006590), 1:1000) and 1:2500, chicken anti-GFP (Aves Labs, Tigard, OR, USA 0511FP12) overnight at 4°C. After thorough washing in Carrier Solution, brain slices were incubated with secondary antibodies (Alexa Fluor-555-conjugated goat anti-mouse IgG, Alexa Fluor-555-conjugated goat anti-rabbit IgG, Alexa Fluor-488-conjugated goat anti-chicken IgG, Life Technologies, Carlsbad, CA, USA) diluted in Carrier Solution (1:1000) at room temperature for 1-2 h. Following another thorough wash in 1 × PBS, sections were mounted on gelatincoated slides with Prolong Gold Antifade Mountant (Life Technologies).
For embryonic immunohistochemistry, mouse embryos were removed at E16.5 and heads were drop fixed in 4% paraformaldehyde/1 × PBS solution overnight at 4°C. Brains were then removed and cryoprotected using a 25% sucrose/1 × PBS solution. Brains were then embedded in optimal cutting temperature compound and frozen at − 80°C. Eighteenmicrometre coronal sections were cut using a cryostat and slide mounted. Labeling for CB1R and GFP in embryonic tissue was performed as described above.
For CCK staining, brain slices were treated with 3% H 2 O 2 /1 × PBS at room temperature for 30 min before permeabilization and blockage. After incubation with mouse anti-CCK (CURE, 1:1000) at 4°C for 48 h, slices were incubated with biotinylated goat anti-mouse IgG (Vector Laboratories Burlingame, CA, USA, 1:200) for 2 h at room temperature. Mouse ABC Elite kit (Vector Laboratories) was used for detection in combination with tetramethylrhodamine-conjugated tyramide (TSA System, Perkin Elmer, Richmond, CA, USA), to amplify and visualize the signal.
For cell counting, fluorescent images were captured using an Olympus AX-70 fluorescent microscope with a Retiga 4000 R cooled CCD camera (Qimaging, Surrey, BC, Canada). At least three independent pairs from three separate litters of VH control and THC-or WIN-treated mice were used at postnatal day 20-30 (P20-P30) for quantitative analysis. For each INT marker, × 10 images of hippocampi from four non-adjacent sections from each mouse were used to count in the CA1-CA3 area. For GFP+ cell counts, we focused on the granule cell-hilar border of the dentate gyrus, an area enriched with CCK-INTs, 23 as the promiscuity of CCK immunoreactivity in this region precludes analysis of CCK-INT density (for example, see Figure 1a ).
For analysis of CB1R labeling, high-resolution single confocal images were taken using a × 63 water-immersion objective on a Zeiss LSM 510 microscope (Zeiss Microscopy, Thornwood, NY, USA). Counting was performed on four hippocampal sections from each animal. Quantitative analysis of CB1R-positive puncta density in the CA1 pyramidal cell (PC) layer was performed using ImageJ (NIH, Bethesda, MD, USA). Watershed parameters that best approximated manual puncta determination were established for each set of VH-and exogenous CB-treated mice, and applied universally to all sections in that set. Images were converted to binary using ImageJ's automated 'Make Binary' function.
Electrophysiology
Hippocampal slices (300 μm thick) were prepared from P14-P45 WIN-or VH-treated mice as indicated. Animals were anesthetized with isoflurane and the brain was dissected in ice-cold saline solution (in mM): 130 NaCl, 24 NaHCO 3 , 10 glucose, 3.5 KCl, 1.25 NaH 2 PO 4 , 1 CaCl 2 and 5 MgCl 2 , saturated with 95% O 2 and 5% CO 2 , pH 7.4. Horizontal hippocampal slices were cut using a VT-1000 S vibratome (Leica Microsystems, Bannockburn, IL, USA) and incubated in saline solution at 35°C until recording. Slices were transferred to a submerged recording chamber and perfused (3-5 ml min − 1 , 32-35°C) with artificial cerebrospinal fluid (in mM): 130 NaCl, 24 NaHCO 3 , 10 glucose, 3.5 KCl, 1.25 NaH 2 PO 4 , 2.5 CaCl 2 and 1.5 MgCl 2 saturated with 95% oxygen and 5% CO 2 , pH 7.4. For feedforward inhibition experiments CaCl 2 was increased to 4.5 mM, to enhance the efficacy of synaptic transmission, and recordings were done in the presence of the GABA B receptor antagonist CGP55845 (1 μM). dl-AP5 (50-100 μM) and DNQX (10 μM) was applied to artificial cerebrospinal fluid, to isolate spontaneous inhibitory postsynaptic currents (sIPSCs) during recordings of spontaneous activity and IPSCs during monosynaptically evoked experiments, and 10 μM bicuculline was used to confirm the inhibitory nature of the responses. Spontaneous excitatory postsynaptic currents (sEPSCs) were pharmacologically isolated with 10 μM bicuculline. In addition, 250 nM AgTx, 1 μM WIN, 10 μM CCh and 10 μM AM251 were used as specified. CA1 PCs were visually identified using IR-DIC video microscopy (Hamamatsu Orca-ER, Middlesex, NJ, USA) and were targeted for whole-cell recording using a computer-controlled multiclamp 700A amplifier (Axon Instruments, Foster City, CA, USA). Putative CCK-INTs were identified in 5HT3AR-GFP mice by GFP expression excited by a Lambda SC light source (Sutter Instruments, Novato, CA, USA) and visualized online via video fluorescence microscopy (Hamamatsu Orca-ER). Recording electrodes (5-7 MΩ) were pulled from borosilicate glass (WPI, Sarasota, FL, USA) and filled with one of three intracellular solutions (in mM): (1) Recordings of sEPSCs, sIPSCs, evoked IPSCs and unitary IPSCs were performed at a holding potential of − 70 mV. For each cell, all detected events were averaged to create a representative sIPSC or sEPSC waveform, which was used for analysis of amplitude. For depolarization-induced suppression of inhibition (DSI) of sIPSCs, slices were treated with CCh to enhance the CCK-INT-mediated portion of sIPSC inhibitory drive. 24 sIPSC DSI was evoked by applying a voltage step from − 70 mV to 0 mV for a duration of 5 s,~1 min after onset of CCh-evoked activity. Amplitude, frequency and charge (area under the curve) were measured in 5 s bins preceding and following the depolarization. DSI was calculated by expressing amplitude, frequency and charge following the depolarization as a percentage of baseline values obtained before the 5 s depolarization. Synaptic stimulation was applied via a constant current isolation unit (A360, WPI) connected to a patch electrode filled with oxygenated artificial cerebrospinal fluid. Synaptic events for disynaptic feedback inhibition and monosynaptic basket cell inhibition experiments were evoked by low intensity stimulation (200 μs/10-80 μA) in the alveus and CA1 PC layer, respectively. During feedback inhibition experiments, CA1 PC population spikes were monitored with a field-recording electrode filled with artificial cerebrospinal fluid placed in stratum pyramidale (SP). Disynaptic feedforward inhibition was evaluated in the Schaffer collateral to CA1 PC pathway by placing the stimulating electrode in CA1 stratum radiatum in slices with a cut made between CA3 and CA1, to prevent recurrent excitation of the CA3 network. To eliminate any potential confounding monosynaptic IPSC contamination of feedforward inhibitory waveforms, events obtained in the presence of DNQX were digitally subtracted from baseline feedforward inhibitory waveforms. Only recordings with monosynaptic IPSC contamination of o50% were included for analysis. For paired recordings, presynaptic INT action potentials were evoked by a 2-ms current step of 2 nA from − 70 mV, while holding the postsynaptic PC at − 70 mV in voltage clamp.
Twenty-five pulse trains at 50 Hz were delivered every 10 s for analysis of asynchronous release. To determine asynchronicity, the area under the curve was measured from a 300-ms window centered on the peak of the last action potential in the evoked train. The area under the curve of a 150 ms window immediately preceding the train was then subtracted to account for the contribution of sIPSCs. Three trials were measured and averaged, to determine the amount of asynchronous release for each cell. For DSI, two 2-ms current steps at 50 Hz were delivered presynaptically every 10 s. The postsynaptic cell was depolarized for 2 s to 0 mV before every fourth trial. DSI was calculated as the percent change in amplitude of 10 IPSCs recorded immediately preceding depolarization and 10 IPSCs recorded after the depolarization. All data were acquired at a sampling rate of 10 kHz using Pclamp10.2 (Molecular Devices, Sunnyvale, CA, USA) and filtered at 3 kHz.
Unitary analysis was performed for paired recordings. For each cell, a minimum of 20 trials were analyzed. Potency was determined as the amplitude of the postsynaptic response without failures, while unitary amplitude included failures. For paired pulse ratio, a pair of presynaptic action potentials was delivered at 50 Hz and the amplitude of the second postsynaptic response was divided by the amplitude of the first postsynaptic response. Latency was measured as the time from the peak of the presynaptic action potential to the beginning of the postsynaptic response. Jitter was then measured as the s.d. of the latency across 20 or more trials for each cell.
Cell morphology
Slices containing biocytin-filled cells were drop fixed in 4% paraformaldehyde overnight at 4°C, then permeabilized and incubated with Alexa-555conjugated avidin (Molecular Probes, Eugene, OR, USA). Following multiple washes, slices were resectioned (70 μm) on a freezing microtome (Microm, Waltham, MA, USA) and mounted on gelatin-coated slides using Mowiol (Calbiochem, San Diego, CA, USA) mounting medium. Stacked Z-section images of recorded cells revealed by biocytin conjugation were obtained with a Leica TCS SP2 RS confocal microscope. Semi-automated threedimensional reconstruction was performed for each cell using the Simple Neurite Tracer plugin for ImageJ. Sholl analysis for each cell was performed on compressed image stacks of the reconstructed cells in ImageJ. Terminal density was determined by counting the number of boutons along a randomly selected continuous~100 μm section of axon in single optical sections. Boutons were visually identified as enlarged varicosities/puncta along the parent axon. 25 Precise length of the sampled axon segment was 
Behavioral analyses
For behavioral testing we used adult 5HT3A-GFP males treated prenatally with either WIN or VH. All animals were 8-12 weeks old at the time of testing. All tests were done during the light phase. Social interaction was tested using a three-chamber apparatus as previously described. 26 The apparatus was made of clear plexiglass with each chamber measuring 20 cm × 40.5 cm × 22 cm and with openings of 10 cm × 5 cm in the dividing walls, allowing free access. Three 10-min trials were performed in succession for each mouse. For the first 10 min, the mouse was confined to the center of the apparatus and allowed to habituate. For the second 10-min trial, the doors were removed for the outside chambers and the mouse was allowed to freely explore the entire apparatus. For the third trial, a wire pencil holder was placed in one side chamber, representing the novel object and a wire pencil holder with a non-littermate wild-type C57/ BL6 male was placed in the other side chamber. Mice were then allowed to freely explore the arena. Entries into the chambers, as well as distance and immobility measurements were analysed using ANY-maze (Stoelting, Wood Dale, IL, USA). Interaction time was measured manually by a blinded observer with interaction being defined as sniffing of either the wire cup or wire cup with the mouse. The mouse was considered to be sniffing when the subject's nose was directed at the wire cup and the distance between the nose and the cup was less than~2 cm. Anxiety-like behavior was measured using the elevated plus maze (San Diego Instruments, San Diego, CA, USA), which consisted of an elevated platform in the shape of an equilateral cross (height: 38.75, platform width: 5 cm, arm length: 30.5 cm), with two opposing arms protected by walls (height: 15.25 cm). The mice were initially placed in the center of the apparatus facing the closed arms and were allowed to free explore the apparatus for 10 min. Any mice that fell off the apparatus (n = 1) were immediately returned to the apparatus at the approximate location of the fall and the behavior was noted. Each session was video recorded and analyzed using ANY-maze software (Stoelting).
Real-time reverse transcriptase-PCR
Hippocampi from P30 VH-and WIN-treated mice were isolated. Total RNA was prepared using an RNAqueos-4PCR kit (ThermoFisher Scientific, Waltham, MA, USA). cDNA was generated using a High Capacity RNA-to-cDNA kit (Applied Biosystems, Foster City, CA, USA 20 (and see Supplementary Figure 1 ). Thus, to focus our study on INTs, we modeled chronic recreational prenatal cannabis use with daily intraperitoneal injections of exogenous CBs (primarily WIN (0.75 mg kg − 1 , but also THC (5 mg kg − 1 ) in a subset of experiments) in pregnant mice from E10.5 until birth and compared the offspring with those from VH-treated controls. Exogenous CB doses were chosen to mimic moderate cannabis use without disrupting pregnancy success rates. 27, 28 Indeed, prenatal injections did not adversely affect pregnancy outcomes, as there were no differences between VH-and WIN-treated mothers in the rate of weight gain during pregnancy, litter size and pup weight gain postnatally ( Supplementary Figure 2) . Following prenatal injections, we examined the density of select hippocampal INT populations in pups aged P20-P30 when INT densities have reached mature levels and specific INT markers are sufficiently expressed for immunohistochemistry. 29 To verify whether the CCK-INT reduction results from cell loss or reduced immunoreactivity of CCK-8, we examined GFP expression in 5HT3AR-GFP mice that comprehensively label CGE-derived INTs, including CCK-INTs. We focused on the dentate granule cell-hilar border, an area known to be enriched in CCK-INTs, 19 but where CCK immunolabeling within mossy fibers precludes analysis of CCK-INTs using immunohistochemistry in the mouse (for example, see Figure 1a ). For comparison, we also examined NKX2.1-cre: RCE-GFP mice that label medial ganglionic eminence-derived INTs, including PV+ and SOM+ populations. 31, 32 GFP+ cell density was significantly reduced in 5HT3AR-GFP mice but not in NKX2.1-cre: RCE-GFP mice following prenatal WIN treatment (Figure 1d ). In fact, GFP+ cell density was significantly reduced throughout the entire hippocampus of 5HT3A-GFP mice following in utero WIN exposure, with deficits emerging as early as P10 ( Supplementary  Figure 3 ). Thus, with regards to effects on hippocampal INTs, chronic prenatal exogenous CB exposure promotes selective loss of CGE-derived CCK-INTs. It is worth noting that although CCK-INTs were the only population examined to reliably exhibit a deficit, other INT subpopulations trended towards being reduced as well.
Modest changes in the CGE-derived vasoactive intestinal peptide+ population may reflect the limited overlap of this population with CCK-basket cells (CCK-BCs) 33, 34 and a minor cohort of immature CGE-derived calretinin+ INTs express CB1Rs. 20 These observations combined with our reliable CCK-INT deficit could reflect a cell autonomous effect of prenatal WIN treatment on CB1R-expressing INT cohorts. However, the weak trends for reduced PV and SOM immunoreactive INTs following WIN treatment would be difficult to reconcile with a cell autonomous effect on CB1R-expressing populations. Indeed, although SOM and CCK transcripts have been found in single developing INTs 11 and one report has suggested functional CB1R expression in mature neocortical SOM-INTs, 35 PV and SOM MGE-derived INT cohorts are not generally recognized to express CB1Rs. As we did not observe significant changes in the overall NKX2.1-cre:RCE-GFP population, the modest changes in PV and SOM immunoreactivities could be secondary to altered network-driven changes in the expression of these activity-regulated proteins. 36 Consistent with the loss of CCK-INTs, WIN-treated mice exhibited a significant reduction in the density of CB1R+ boutons in SP, the major axon termination zone of perisomatic targeting CCK cells (Figure 1e) . A previous study suggested that prenatal exogenous CB treatment disrupts CB1R+ terminal basket formation in the cortex due to impaired axon targeting. 15 However, morphological evaluation of 5-HT3AR-GFP+ basket (BC) and SCA cells, two major subtypes of CCK-INTs, 37 revealed comparable axon trajectories and bouton densities between WIN-and VH-treated mice (Figures 1f and g) . Thus, the decrease in CB1R+ terminals innervating SP in WIN-treated mice primarily reflects reduced absolute CCK-INT numbers rather than gross defects in residual CCK-INT axonal patterning. Further evaluation revealed decreased dendritic complexity of both CCK-BCs and SCAs in WIN-treated animals as well as decreased overall dendritic length in CCK-BCs (Figures 1f, h and i) . These dendritic alterations are consistent with eCB regulation of neurite development in culture 11 and could impair circuit recruitment of remaining CCK-INTs.
CB1Rs are also present on forebrain glutamatergic principal neurons and developmental disruption of eCB signaling in these cells impairs long-range corticofugal and corticospinal axon projections. 14, 15, 17, 18, 38 * deficit in prenatally WIN-treated pups was accompanied by changes within the hippocampal PC population. Analysis of PC densities in the CA1 hippocampal region of P20-P30 mice did not reveal any differences between VH-and WIN-treated animals (Figure 2b ). In addition, prenatal WIN exposure did not produce any obvious defects in axonal projections within the fimbria and corpus callosum (Figure 2a ). Morphological analysis of individual cells also showed that dendritic length of CA1 PCs was comparable in VH-and WIN-treated mice (Figure 2c ). Moreover, maternal WIN treatment did not alter basic excitatory synaptic properties of hippocampal PCs as CA1 sEPSCs and Schaffer collateral-evoked synaptic input-output relations were similar in pups from VH-and WIN-treated groups (Figures 2d and e ). Taken together, these findings indicate that prenatal WIN exposure affects CGE-derived CCK-INTs without overt disruption of hippocampal PCs.
Prenatal exogenous CB treatment reduces CCK-INT mediated spontaneous, feedforward and feedback inhibition
To assess the impact of prenatal WIN exposure on inhibitory function, we electrophysiologically assayed CA1 PC sIPSCs in agematched (P14-P25) VH-and WIN-treated mice. Initially, we found no difference in the amplitude or frequency of pharmacologically isolated sIPSCs recorded from animals treated with WIN or VH ( Supplementary Figure 4 ). Although these findings appear inconsistent with a loss of CCK-INTs, sIPSCs capture events mediated by various INT subtypes. To specifically assay CCK-INTmediated spontaneous inhibition, we probed the extent of DSI. DSI reflects an eCB-mediated retrograde signal that inhibits GABA release from presynaptic CCK-INTs and can be evoked by depolarizing recorded PCs to promote eCB production and release. 39, 40 Cells recorded from animals prenatally treated with WIN exhibited significantly less DSI compared with VH controls (Figure 3a) . Importantly, in paired recordings between individual, CCK-INTs and PCs DSI remained intact in WIN-treated mice (see below, Figure 4) , indicating that the reduction in DSI-sensitive spontaneous inhibition probably results from reduced CCK-INTs rather than altered eCB signaling.
To further probe CCK-INT-driven inhibitory tone, we assayed feedback inhibition in the CA1 microcircuit in age-matched (P30-P45) VH-and WIN-treated mice. 41 While recording from CA1 PCs, we stimulated the alveus to evoke back-propagating action potentials in PC axons that disynaptically recruits inhibition from a heterogeneous population of CA1 INTs (Figure 3b ). Acute application of WIN revealed a deficient CCK-INT-mediated component to feedback inhibition in WIN-treated animals (Figure 3c ). Normalizing the degree of CCK-INT-mediated feedback inhibition to overall CA1 PC excitation, measured by simultaneously monitored CA1 population spikes, confirmed a significant disruption in the balance between CCK-INT-driven feedback inhibition and CA1 PC population activity in WIN-treated mice (IPSC/PS ratios in WIN-treated mice were 36.4 ± 11.5% of those in VH-treated mice, VH: n = 16 cells/11 animals/6 litters; WIN: n = 14 cells/9 animals/7 litters, P = 0.04). As the altered dendritic morphology of CCK-INTs in WIN-treated mice could alter synaptic recruitment and different INT subtypes provide distinct temporal contributions to feedback inhibition, 41 we also examined trains of disynaptic IPSCs to increase the opportunity for CCK-INT recruitment. However, prenatally WIN-treated mice continued to exhibit less acute WIN sensitivity of disynaptic IPSCs throughout the train (Figure 3e) .
Recent evidence suggests that CCK-INTs also significantly contribute to feedforward inhibition in the hippocampal CA3 to CA1 pathway. 42 To assess feedforward inhibition, we recorded from CA1 PCs while stimulating Schaffer collaterals in CA1 stratum radiatum (Figure 3f ). For these experiments, the chloride reversal potential was set to − 80 mV and CA1 PCs were held at − 30 mV so that disynaptic inhibitory components could be easily separated from monosynaptic excitatory events. Consistent with the observed loss in CCK-INTs, WIN-treated mice exhibited reduced DSI sensitivity of feedforward inhibition (Figure 3f ). Thus, prenatal exogenous CB exposure significantly alters circuit inhibition dynamics in a manner consistent with CCK-INT loss.
In utero exogenous CB exposure reduces constitutive CB1R activity but preserves other basic synaptic properties of residual CCK INTs Constitutive CB1R activation inhibits transmitter release from CCK-BCs. Thus, CB1R antagonism increases CCK-BC release probability, yielding a larger IPSC, 43 and the degree of this basal CB1R activity scales with ongoing circuit activity. 44 To examine whether the reduction in CCK-INTs following prenatal WIN exposure homeostatically changes constitutive CB1R inhibition of residual CCK-BC output, we recorded CA1 PCs, while stimulating SP to evoke monosynaptic IPSCs from CCK-BCs in slices from age-matched (p14-P25) VH-and WIN-treated mice (Figure 4a ). Slices were incubated with ω-agatoxin IVa (250 nM) to prevent PV-BC output, 45 and the remaining CCK-BC-driven IPSC was probed for constitutive CB1R activity. The CB1R antagonist AM251 increased the amplitude of monosynaptically evoked IPSCs for both single events and trains of events in VH-treated animals (Figures 4a and  b) . However, this effect was absent in animals prenatally exposed to WIN, revealing a loss of constitutive CB1R activation in residual CCK-BCs (Figures 4a and b) . Although reduced constitutive CB1R activity following in utero WIN exposure may serve to maximize the function of remaining CCK-INTs during basic circuit activity, more complex computations requiring activity-dependent scaling of CCK-BC synapses could suffer.
To further examine the synaptic properties of residual CCK-INTs in mice treated prenatally with WIN, we recorded connected CCK-BC and SCA to PC pairs in slices from age-matched (P14-P25) VH-and WIN-treated mice (Figure 4c ). Both CCK-BCs and SCAs had similar potency, unitary amplitude, release probability, latency and jitter between VH-and WIN-treated animals (Supplementary Figure 5 ). Despite the lack of constitutive CB1R activity in WINtreated CCK-BCs, we observed similar DSI levels between VH-and WIN-treated mice confirming normal CB1R function at remaining CCK-INT to PC connections (Figure 4c ). This also confirms that activity-driven eCB signaling in PCs remains intact following in utero WIN treatment, consistent with quantitative reverse transcriptase-PCR data, showing no difference in the relative abundance of the eCB synthesizing (diacylglycerol lipase α (DAGLα)) or hydrolyzing (monoacylglycerol lipase (MAGL)) enzymes, in VH-and WIN-treated mice ( Supplementary Fig 6) . CCK-INTs in both VH-and WIN-treated animals also exhibited prominent asynchronous release during high-frequency activity, a hallmark feature of CCK-INT transmission (Figure 4d ). Thus, the basic synaptic properties of remaining CCK-INTs are largely preserved following prenatal exogenous CB exposure. Deficits in social interaction following prenatal exogenous CB exposure Finally, we investigated potential behavioral consequences of CCK-INT deficits in WIN-treated animals. Although there is currently no evidence linking CCK-INT dysfunction to particular behavioral phenotypes, autism-associated neuroligin-3 mutants exhibit reduced constitutive CB1R activity at CCK-INT to PC synapses, similar to our findings in WIN-treated mice. 46 Moreover, perinatal exogenous CB treatment reduces social interaction in rats. 47 Thus, we used the three-chamber social interaction test to assay social behavior ( Figure 5a ). We found no difference between WIN and VH treatment groups in the number of entries made into the chamber containing either the novel mouse or object (Figure 5b ). However, WIN-treated mice spent significantly less time interacting with the novel mouse compared with VH controls, indicating a deficit in social interaction (Figure 5c ). This deficit is not an indirect effect of increased anxiety, as on the elevated plus maze we found no difference between WIN-and VH-treated animals in the number of entries/time spent in the open or closed arms or the number of head dips (Figures 5d-f ). These findings indicate that prenatal exposure to exogenous CBs results in specific deficits in social interaction. Although our findings of disrupted CCK-INT function and altered social behavior are only correlational, a potential mechanistic link would be consistent with similar social deficits in the neuroligin-3 mutant model, which also lacks constitutive CB1R activity.
DISCUSSION
The effect of prenatal and perinatal exposure to exogenous CBs on behavioral outcomes has been well documented in animal models and humans. However, little is known about the effect of prenatal CB exposure at cellular and molecular levels. In this study, we present evidence that prenatal exposure to exogenous CBs has an impact on the development of hippocampal CCK-INTs. Our data indicate that in utero exposure to CB1R agonists significantly reduces the density of CCK-INTs and, similarly, reduces CB1R+ bouton density in CA1 stratum pyramidal. These anatomical deficits result in a significant decrease in CCK-INT-mediated spontaneous inhibition and deficits in CCK-INT-mediated feedforward/feedback inhibition in the CA1 microcircuit. Further, prenatal exposure to WIN significantly reduced dendritic complexity and overall dendritic length, and reduced constitutive CB1R activity in residual CCK-INTs. Finally, we show that prenatal WIN exposure produces deficits in social interaction, suggesting CCK-INT loss may contribute to the generation of persistent neurobehavioral deficits observed in individuals prenatally exposed to cannabis. Two recent studies have examined the impact of prenatal exposure to exogenous CBs on cortical circuitry and neuronal migration, respectively. 15, 22 In the former, Tortoriello et al. 15 showed that repeated Δ9-THC exposure during midgestation modulates SCG10/stathmin-2 availability, ultimately inducing alterations to cytoskeletal elements in fetal neurons. This results in disruption of cortical circuitry, including the patterning and directional growth of fetal corticofugal axons. In the latter, Saez et al. 22 showed that subcutaneous injection of WIN beginning at gestational day 5 disrupts both radial and tangential migration within the cortex, increasing the number of migrating GABAergic neurons during late gestation, while leaving cortical apoptosis unaffected. Previous studies also revealed an increase in CCK mRNA in the hippocampus following prenatal THC treatment and impaired postsynaptic target selection among a subpopulation of vesicular glutamate transporter 3 (Vglut3)-expressing CCK-INTs in mice with conditional CB1R deletion. 11, 12 Although these findings contrast with our study, the techniques used lack the specificity to precisely examine the CCK-INT population currently examined. CCK mRNA is promiscuous within the hippocampus and can be found in a variety of INTs 48 Further study is required in order to assess whether prenatal WIN or THC treatment has variable effects on distinct CCK-INT subpopulations.
Despite these incongruities, these studies, as well as ours, add to a growing base of literature on the role of CB1Rs and eCB signaling in the developing brain. Evidence indicates a role for CB1Rs in neuronal proliferation, specification, migration and axon outgrowth, supporting a model where the dynamic balance of the eCB synthesizing (DAGL) and hydrolyzing (MAGL) enzymes governs the role of CB1R signaling in these various phases of development. [11] [12] [13] 49 The location of DAGL and MAGL at various phases of development provides spatial and temporal control over eCB signaling, delivering cell-state-specific regulation of CB1R activation. 50 As exogenous CBs are insensitive to hydrolysis by MAGL, they can disrupt the spatial organization of eCB signaling and, consequently, disrupt the developmental programs governed by CB1Rs. 15, 50 Although the selective loss of CCK-INTs suggests a cell autonomous mechanism, evidence linking prenatal CB exposure to disruption of corticofugal and corticospinal axon projections from forebrain glutamatergic principle neurons suggests potential for non-cell autonomous mechanisms as well. Disruption of distinct principle cell subpopulations may alter the extracellular milieu during development, disrupting chemical gradients necessary for tangential cell migration or cell survival cues, and could precipitate CCK-INT deficits. Although our findings did not attempt to identify the specific aspect of CCK-INT development that is disrupted by exogenous CB application, our anatomical and physiological findings contribute to the nascent body of literature describing CB-mediated disruption of neuronal development. Further research is needed to elucidate the specific mechanism underlying the deficits in CCK-INT density and function found in our model of prenatal CB exposure.
Previous studies indicate that pre/perinatal exogenous CB exposure is associated with a variety of neurobehavioral defects. 47, [51] [52] [53] Interestingly, in our model we found that prenatal WIN exposure was associated specifically with deficits in social interaction but not anxiety-related behavior. These discrepancies could correspond to differences in the treatment window and differences in the animal model. In previous studies that showed anxiogenic behavior, altered social behavior and deficits in learning-and memory-related tasks, exogenous CBs were applied perinatally from E15 to P9 (refs 47,52) . As the role of developmental eCB signaling is age dependent, both timing and duration of exogenous CB exposure probably dictates which aspects of eCB-dependent neuronal development and maturation are affected, influencing the observed phenotype. 54 Our findings add to the growing body of evidence implicating altered excitation/inhibition balance in a variety of neuropsychiatric disorders, including autism spectrum disorders, schizophrenia and epilepsy. [55] [56] [57] [58] However, the correlation between hippocampal CCK-INT deficits and the observed deficits in social behavior remains unclear. A recent study showed that adolescent CB exposure is associated with alterations in GABAergic tone in prefrontal cortex, an area implicated in social information processing, suggesting local prefrontal cortex disruption of CCK-INT number and function could underlie the observed behavioral phenotype. 57, 59 However, promiscuity of the CCK antibody within mouse cortical regions currently precludes analysis of CCK-INT density in the cortex, limiting our ability to assess the effect of prenatal CB exposure on cortical CCK-INT development. Further, although our model shows a specific deficit in hippocampal CCK-INTs, evidence suggests distinct subpopulations of cortical excitatory neurons may be affected by prenatal CB exposure as well. This indicates the observed behavioral phenotype may be precipitated by alterations to both CCK-INTs and specific PC subpopulations. 15, 18 CB1R activation is a critical modulatory mechanism inhibiting transmitter release from CCK-INT synapses in both activitydependent and constitutive manners. 60 Previous findings show that constitutive CB1R activity can be reduced by chronic treatment with tetrodotoxin or deafferenting organotypic slice cultures, indicating constitutive CB1R activity may provide a homeostatic mechanism that scales specific CB1R+ synapses. 44 Alterations in constitutive CB1R activity have also been shown in two neuroligin-3 mutants associated with autism spectrum disorders, one of which, neurlogin-3 R541C, displays significant increases in hippocampal E/I ratio. 46, 61 These findings along with those presented in this study suggest that disruption of constitutive CB1R activity may be an important hallmark of E/I imbalance in specific neuronal circuits. As the E/I ratio of a particular circuit increases, tipping the balance towards excitation, a reduction in tonic eCB signaling can increase inhibition mediated by CCK-INTs in an attempt to restore balance.
Overall, this study presents an examination of the effect of prenatal exogenous CB exposure on a specific CB1R+ cell population. These findings add to a nascent body of evidence on the impact of in utero cannabis exposure on fetal development and provide a potential cellular mechanism for the persistent neurobehavioral deficits observed in individuals prenatally exposed to cannabis. Although regulatory obstacles have made studies on prenatal cannabis exposure difficult, the increasing prevalence of cannabis consumption, precipitated by changes in the legal and social status of the drug, necessitates further research on embryonic exposure. In addition, the rising THC content of recreational cannabis strains and increasing popularity of potent cannabis-derived products make the need for information on prenatal cannabis exposure more pressing as even moderate exposure could prove deleterious.
